On June 23, 2014, Ivera Medical Corporation and Becton,
Dickinson, and Company (plaintiffs) alleged infringement against
Hospira, Inc. (defendant). Prior to trial, the parties exchanged
motions in limine. In granting and denying in part the parties'
motions, the court granted plaintiffs' motion in limine
regarding inter partes review proceedings. Plaintiff's argued
that defendant should not be allowed to submit evidence or argument
regarding institution of the inter partes review of the asserted
patent. Defendant opposed the motion arguing that the inter partes
proceedings were part of the patent prosecution history and
probative of the relevance of prior art.
In granting plaintiff's motion in limine, the court relied
on the difference in standards – "a reasonable
likelihood that the petitioner would prevail" contrasted with
the "clear and convincing" standard. The court also noted
that after the Patent Trial and Appeal Board (PTAB) instituted
inter partes review,